Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310589) titled 'Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: National Taiwan University Hospital
Condition:
Non-Small Cell Lung Cancer
Intervention:
Behavioral: Visual-Interactive LINE Chatbot
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2026
Target Sample Size: 178
To know more, visit https://clinica...